LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Liquid Media Found Practical for Diarrheagenic Parasite

By LabMedica International staff writers
Posted on 12 Dec 2011
Image: The anaerobic intestinal protozoan Blastocystis hominis (Photo courtesy of K-State).
Image: The anaerobic intestinal protozoan Blastocystis hominis (Photo courtesy of K-State).
A common protozoan in the human intestinal tract that can cause the so-called blastocystosis characterized by diarrhea, can be grown in liquid culture media.

In vitro culture methods could be safe alternatives to identify Blastocystis hominis for both clinical diagnosis and field study purposes, as present methods are potentially toxic to laboratory personnel.

Scientists at Xi’an Jiaotong University (China) isolated eight samples of B. hominis from symptomatic patient fresh stool samples. More than five B. hominis cells were seen per high-power magnification field. To determine whether in vitro culture could be an environmentally safe alternative, the culture growth of B. hominis observed and compared in three commercially available liquid media: Roswell Park Memorial Institute (RPMI) 1640, 199 Medium, and Dulbecco's modified Eagle's medium (DMEM). The sensitivity and specificity of these culture methods to identify B. hominis were compared with those of existing methods used clinically.

The anaerobic culture of B. hominis in these media required a total inoculum sizes of no less than 105 cells; pH values ranging from 7.0 to 7.5; concentrations of calf or horse serum ranging from 10% to 30%; and basic antibiotics have to be added. Growth peaking times were at days 3, 6, and 9 at pH 7.5 or days 4 and 8 or 9 at pH 7.0 at 37 °C. No significant differences were noted in multiplication or generation times for the cultivation of B. hominis. In 56 of 398 positive cases, the short-term in vitro culture method achieved the best performance with regard to sensitivity and specificity of the five methods studied. All three culture media were from the Gibco (Carlsbad, CA, USA) range of culture media. B. hominis identification has depended on the discovery of vacuolar, granular, amoebic, or cystic forms in stool samples using wet mount smears, iodine staining, trichrome staining, or iron hematoxylin staining.

The authors concluded that the in vitro culture method had the advantage of environmental safety, convenience in preparation and storage, facility in morphologic discrimination, and outstanding performance in terms of sensitivity and specificity, and could be applied to identify B. hominis for clinical diagnosis except in emergency situations. Prevalence surveys in China suggest that about 6% of patients with diarrhea have blastocystosis. The study was published on November 11, 2011, in the International Journal of Infectious Diseases.

Related Links:

Xi’an Jiaotong University
Gibco


Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more